Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZEAL-UNLOCK in cirrhosis
jRCT2031230669Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2024
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial in Cirrhosis comparing Zibotentan + dapagliflozin, Zibotentan monotherapy and Placebo (3 arms). Started Feb 2024; status: completed.
02
Drugs
zibotentandapagliflozin
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on jRCT2031230669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230669.